The responses of the hepatic and splanchnic vascular beds to vasopressin in rats

Biomedical Research

Volumn 33, Issue 2, 2012, Pages 83-88

  Zhang, Wei ^a,b   Shibamoto, Toshishige ^a   Kuda, Yuhichi ^a   Shinomiya, Shohei ^a   Kurata, Yasutaka ^b  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b QINGHAI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTERY BLOOD FLOW; ARTICLE; BLOOD FLOWMETRY; BOLUS INJECTION; CENTRAL VENOUS PRESSURE; DOSE RESPONSE; DRUG RESPONSE; HEPATIC ARTERY; ISOLATED LIVER; LIVER BLOOD VESSEL; LIVER PERFUSION; NONHUMAN; PORTAL VEIN; PORTAL VEIN BLOOD FLOW; PORTAL VEIN BLOOD PRESSURE; RAT; SPLANCHNIC BLOOD FLOW; SPRAGUE DAWLEY RAT; VASCULAR RESISTANCE; VASOCONSTRICTION; VENOCONSTRICTION;

ANIMALS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; LIVER; MALE; PORTAL PRESSURE; RATS; RATS, SPRAGUE-DAWLEY; SPLANCHNIC CIRCULATION; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

RATTUS;

EID: 84860627210     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.33.83     Document Type: Article

References (24)

1. Barrett LK, Singer M and Clapp LH (2007) Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med 35, 33-40.
2. Bichet DG, Razi M, Lonergan M, Arthus MF, Papukna V, Kortas C and Barjon JN (1988) Hemodynamic and coagulationresponses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus. NEngl J Med 318, 881-887.
3. Evora PR, Pearson PJ and Schaff HV (1993) Arginine vasopressin induces endothelium-dependent vasodilatation of the pulmonary artery. V1-receptor-mediated production of nitric oxide. Chest 103, 1241-1245.
4. Greenway CV and Lautt WW (1972) Effects of infusions of catecholamines, angiotensin, vasopressin and histamine on hepatic blood volume in the anaesthetized cat. Br J Pharmacol 44,177-184.
5. Kaufmann JE, Lezzi M and Vischer UM (2003) Desmopressin (DDAVP) induces NO production in human endothelial cells via V2 receptor- and cAMP-mediated signaling. J Thromb Haemost 1, 821-828.
6. Landry DW, Levin HR, Gallant EM, Ashton RC Jr, Seo S, D'Alessandro D, Oz MC and Oliver JA (1997) Vasopressindeficiency contributes to the vasodilation of septic shock. Circulation 95, 1122-1125.
7. Liu W, Takano H, Shibamoto T, Cui S, Zhao ZS, Zhang W and Kurata Y (2007) Involvement of splanchnic vascular bed in anaphylactic hypotension in anesthetized BALB/c mice. Am J Physiol Regul Integr Comp Physiol 293, R1947-R1953.
8. Malay MB, Ashton RC Jr, Landry DW and Townsend RN (1999) Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 47, 699-703.
9. Okamura T, Toda M, Ayajiki K and Toda N (1997) Receptor subtypes involved in relaxation and contraction by arginine vasopressin in canine isolated short posterior ciliary arteries. J Vasc Res 34, 464-472.
10. Okamura T, Ayajiki K, Fujioka H and Toda N (1999) Mechanisms underlying arginine vasopressin-induced relaxation in monkey isolated coronary arteries. J Hypertens 17, 673-678
11. Rothe CF and Maass-Moreno R (2000) Active and passive liver microvascular responses from angiotensin, endothelin, norepinephrine, and vasopressin. Am J Physiol Heart Circ Physiol 279, H1147-H1156.
12. Rudichenko VM and Beierwaltes WH (1995) Arginine vasopressin- induced renal vasodilation mediated by nitric oxide. J Vasc Res 32, 100-105.
13. Sampson HA, Muñoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, Brown SG, Camargo CA Jr, Cydulka R, Galli SJ, Gidudu J, Gruchalla RS, Harlor AD Jr, Hepner DL, Lewis LM, Lieberman PL, Metcalfe DD, O'Connor R, Muraro A, Rudman A, Schmitt C, Scherrer D, Simons FE, Thomas S, Wood JP and Decker WW (2006) Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 117, 391-397.
14. Schmeisch AP, de Oliveira DS, Ide LT, Suzuki-Kemmelmeier F and Bracht A (2005) Zonation of the metabolic action of vasopressin in the bivascularly perfused rat liver. Regul Pept 129, 233-243.
15. Shibamoto T, Cui S, Ruan Z, Liu W, Takano H and Kurata Y (2005) Hepatic venoconstriction is involved in anaphylactic hypotension in rats. Am J Physiol Heart Circ Physiol 289, H1436-H1441.
16. Suzuki Y, Satoh S, Oyama H, Takayasu M and Shibuya M (1993) Regional differences in the vasodilator response to vasopressin in canine cerebral arteries in vivo. Stroke 24, 1049-1053.
17. Tamaki T, Kiyomoto K, He H, Tomohiro A, Nishiyama A, Aki Y, Kimura S and Abe Y (1996) Vasodilation induced by vasopressin V2 receptor stimulation in afferent arterioles. Kidney Int 49, 722-729.
18. 2+ mobilizing agents from the perfused rat liver. A comparative study on the action of ATP, UTP, phenylephrine, vasopressin and nerve stimulation. Biol Chem Hoppe Seyler 369, 65-68.
19. Walker BR, Haynes J Jr, Wang HL and Voelkel NF (1989) Vasopressin-induced pulmonary vasodilation in rats. Am J Physiol 257, H415-H422.
20. Welt FG and Rutlen DL (1991) Effect of vasopressin on systemic capacity. Am J Physiol Heart Circ Physiol 261, H1494-H1498.
21. Wenzel V, Raab H and Dünser MW (2008) Arginine vasopressin: a promising rescue drug in the treatment of uncontrolled haemorrhagic shock. Best Pract Res Clin Anaesthesiol 22, 299-316.
22. White SF, Dinda PK and Beck IT (1991) The effect of pitressin on esophageal blood flow of the dog. Can J Physiol Pharmacol 69, 1810-1813.
23. Yang MC, Yu PC, Tu MS, Lay CS, Hong CY, Chou CK, Chen CF and Kuo JS (1990) Effects of endothelin and vasopressin on portal pressure of rats. Life Sci 46, 1929-1936.
24. Zhao ZS, Shibamoto T, Tsutsumi M, Cui S, Zhang WM, Takano H and Kurata Y (2009) Mouse hepatic portal venoconstrictive response to vasoconstrictors is much weaker than that in rat. J Cardiovasc Pharmacol 54, 421-426.